Advent Ventures forms company for pharmaceutical acquisitions

Advent Venture Partners, a European venture capital firm, has formed a new company to acquire speciality pharmaceutical prescription products, headed by former Roche, Elan and Xenova veteran Geoff McMillan.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this